Civic AI
Procurement intelligence
Federal contract award
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS TASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIATED COLORECTAL CANCER IMMUNOPREVENTION
THE INSTITUTE FOR CANCER RESEARCH · Department of Health and Human Services
- Value
- $2,051,148
- Start
- Jun 15, 2022
- End
- May 14, 2027
- Action date
- May 12, 2026
- PIID
- 75N91022F00001
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- PHILADELPHIA, PA
- Award type
- DELIVERY ORDER
Description
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS TASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIATED COLORECTAL CANCER IMMUNOPREVENTION
Need modifications, related awards, and vendor peers? Open the full award workspace.